Let’s be honest: the days of fluffy, temporary beauty fixes are over. If you are serious about your skin, you need science, not guesswork. At Mediluxe, we have always championed advanced skin health, utilising medical-grade cosmeceuticals and clinically-proven devices—from HIFU and LED to Skin Needling with active infusion.
The cosmetic world is moving at light speed, and here in Australia, where we invest billions in looking and feeling our best, we are setting the global pace. Today, I want to cut through the noise and share my three non-negotiable predictions for where the aesthetic industry is heading. These are not just fleeting trends; these are the science-backed shifts that will define your skin treatments and home care for the next decade.
Prediction 1: The Era of Combination Therapy—Stacking for Superior Results
My first prediction is the complete dominance of Combination Therapy.
The future of aesthetics—and what we already practice extensively at Mediluxe—is about stacking modalities in one comprehensive protocol to achieve a result that is simply impossible to get with a single treatment.
The Proof is in the Protocol
This trend is driving massive investment right here in Australia. The Australian Aesthetic Devices Market is forecast to expand at an annual growth rate of nearly 10% through to 2030, with Ultrasound-based technologies—like our HIFU—showing some of the strongest growth .
Furthermore, the non-surgical aesthetic market in Australia is soaring at up to 14.1% CAGR . This massive growth confirms that clients are demanding the proven, deep-collagen results that come from stacking clinical devices and active infusion.
Synergy and Infusion at Mediluxe
It is not a matter of choosing HIFU or Skin Needling; it is about combining HIFU with Skin Needling. We use HIFU to target the deep foundation for structural lift, and we complement this with Skin Needling, which stimulates collagen and remodels texture in the upper layers.
For us, Skin Needling is a delivery system. We use medical-grade cosmeceuticals—packed with Growth Factors and Peptides—to flood the deeper dermal layers for maximum cellular repair. That targeted infusion is our 1+1=3 result.